TECHNICAL CORRECTIONS.

SEC. 901. TECHNICAL CORRECTIONS. (a) [21 U.S.C. 355] Section 3075(a) of the 21st Century Cures Act (Public Law 114-255) is amended— (1) in the matter preceding paragraph (1), by striking “as amended by section 2074” and inserting “as amended by section 3102”; and (2) in paragraph (2), by striking “section 2074(1)(C)” and inserting “section 3102(1)(C)”. (b) Section 506G(b)(1)(A) of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 356g(b)(1)(A)) is amended by striking “identity” and inserting “identify”. (c) Section 505F(b) of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 355g(b)) is amended by striking “randomized” and inserting “traditional”. (d) Section 505F(d) of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 355g(d)) is amended by striking “2” and inserting “3”. (e) Section 510(h)(6) of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 360(h)(6)) is amended by striking “February 1” and replacing with “May 1”. (f) Effective as of the enactment of the 21st Century Cures Act (Public Law 114-255)— (1) [21 U.S.C. 360e-3] section 3051(a) of such Act is amended by striking “by inserting after section 515B” and inserting “by inserting after section 515A”; and (2) section 515C of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 360e-3), as inserted by such section 3051(a), is redesignated as section 515B. (g) Section 515B(f)(2) of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 360e-3(f)(2)), as redesignated by subsection (e)(2) of this section, is amended by striking “a proposed guidance” and inserting “a draft version of that guidance”. (h) Section 513(b)(5)(D) of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 360c(b)(5)(D)) is amended by striking “medical device submissions” and inserting “medical devices that may be specifically the subject of a review by a classification panel”.